nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE7A—renal system—cervical cancer	0.0411	0.0755	CbGeAlD
Flavoxate—PDE7A—female reproductive system—cervical cancer	0.0329	0.0605	CbGeAlD
Flavoxate—PDE8B—uterine cervix—cervical cancer	0.0306	0.0562	CbGeAlD
Flavoxate—PDE8A—uterine cervix—cervical cancer	0.0275	0.0506	CbGeAlD
Flavoxate—PDE8A—decidua—cervical cancer	0.0262	0.0482	CbGeAlD
Flavoxate—PDE8B—uterus—cervical cancer	0.0255	0.0468	CbGeAlD
Flavoxate—PDE8A—endometrium—cervical cancer	0.0249	0.0457	CbGeAlD
Flavoxate—PDE8A—mammalian vulva—cervical cancer	0.024	0.0442	CbGeAlD
Flavoxate—PDE8A—uterus—cervical cancer	0.0229	0.0421	CbGeAlD
Flavoxate—PDE8B—female reproductive system—cervical cancer	0.0229	0.0421	CbGeAlD
Flavoxate—PDE4A—decidua—cervical cancer	0.021	0.0386	CbGeAlD
Flavoxate—PDE8B—vagina—cervical cancer	0.0207	0.0381	CbGeAlD
Flavoxate—PDE8A—female gonad—cervical cancer	0.0187	0.0345	CbGeAlD
Flavoxate—PDE8A—vagina—cervical cancer	0.0186	0.0343	CbGeAlD
Flavoxate—PDE4D—female gonad—cervical cancer	0.017	0.0312	CbGeAlD
Flavoxate—PDE7B—lymph node—cervical cancer	0.0168	0.0309	CbGeAlD
Flavoxate—PDE4A—female gonad—cervical cancer	0.015	0.0276	CbGeAlD
Flavoxate—PDE8B—lymph node—cervical cancer	0.0134	0.0246	CbGeAlD
Flavoxate—PDE4B—uterine cervix—cervical cancer	0.0131	0.0242	CbGeAlD
Flavoxate—PDE4B—decidua—cervical cancer	0.0125	0.023	CbGeAlD
Flavoxate—PDE8A—lymph node—cervical cancer	0.012	0.0222	CbGeAlD
Flavoxate—PDE4B—endometrium—cervical cancer	0.0119	0.0219	CbGeAlD
Flavoxate—PDE4B—mammalian vulva—cervical cancer	0.0115	0.0211	CbGeAlD
Flavoxate—PDE4D—lymph node—cervical cancer	0.0109	0.0201	CbGeAlD
Flavoxate—PDE4D—G alpha (s) signalling events—TAAR6—cervical cancer	0.00987	0.0216	CbGpPWpGaD
Flavoxate—PDE4B—female reproductive system—cervical cancer	0.00985	0.0181	CbGeAlD
Flavoxate—PDE4C—G Protein Signaling Pathways—AKAP13—cervical cancer	0.00979	0.0214	CbGpPWpGaD
Flavoxate—PDE4A—lymph node—cervical cancer	0.00966	0.0178	CbGeAlD
Flavoxate—PDE4A—G alpha (s) signalling events—TAAR6—cervical cancer	0.0094	0.0206	CbGpPWpGaD
Flavoxate—CHRM1—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00905	0.0198	CbGpPWpGaD
Flavoxate—PDE4B—female gonad—cervical cancer	0.00896	0.0165	CbGeAlD
Flavoxate—CHRM2—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00894	0.0196	CbGpPWpGaD
Flavoxate—PDE4B—vagina—cervical cancer	0.0089	0.0164	CbGeAlD
Flavoxate—CHRM1—female reproductive system—cervical cancer	0.0089	0.0164	CbGeAlD
Flavoxate—PDE4B—G alpha (s) signalling events—TAAR6—cervical cancer	0.0087	0.0191	CbGpPWpGaD
Flavoxate—PDE4D—G Protein Signaling Pathways—AKAP13—cervical cancer	0.00852	0.0187	CbGpPWpGaD
Flavoxate—PDE4A—G Protein Signaling Pathways—AKAP13—cervical cancer	0.00811	0.0178	CbGpPWpGaD
Flavoxate—PDE4B—G Protein Signaling Pathways—AKAP13—cervical cancer	0.0075	0.0164	CbGpPWpGaD
Flavoxate—PDE4B—lymph node—cervical cancer	0.00576	0.0106	CbGeAlD
Flavoxate—PDE8A—GPCR downstream signaling—TAAR6—cervical cancer	0.00431	0.00944	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—TAAR6—cervical cancer	0.00431	0.00944	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—TAAR6—cervical cancer	0.00391	0.00857	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—TAAR6—cervical cancer	0.00391	0.00857	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—TAAR6—cervical cancer	0.00384	0.00842	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—TAAR6—cervical cancer	0.00357	0.00782	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—TAAR6—cervical cancer	0.00349	0.00764	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—TAAR6—cervical cancer	0.00324	0.0071	CbGpPWpGaD
Flavoxate—PDE4D—TSH signaling pathway—MTOR—cervical cancer	0.00315	0.0069	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—WNT2—cervical cancer	0.00305	0.00669	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—WNT2—cervical cancer	0.00305	0.00669	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—AKAP13—cervical cancer	0.00295	0.00647	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—AKAP13—cervical cancer	0.00295	0.00647	CbGpPWpGaD
Flavoxate—PDE7A—Ectoderm Differentiation—CTNNB1—cervical cancer	0.00273	0.00598	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—WNT2—cervical cancer	0.00272	0.00597	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—AKAP13—cervical cancer	0.00268	0.00588	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—AKAP13—cervical cancer	0.00268	0.00588	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—AKAP13—cervical cancer	0.00263	0.00577	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—WNT2—cervical cancer	0.00253	0.00555	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—AKAP13—cervical cancer	0.00245	0.00536	CbGpPWpGaD
Flavoxate—PDE4D—TSH signaling pathway—STAT3—cervical cancer	0.00243	0.00533	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—AKAP13—cervical cancer	0.00239	0.00524	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—TAAR6—cervical cancer	0.00233	0.0051	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—WNT5A—cervical cancer	0.00232	0.00507	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—WNT5A—cervical cancer	0.00232	0.00507	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TAAR6—cervical cancer	0.00231	0.00507	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TAAR6—cervical cancer	0.00231	0.00507	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—AKAP13—cervical cancer	0.00222	0.00487	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—TAAR6—cervical cancer	0.00211	0.00463	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—WNT5A—cervical cancer	0.00206	0.00452	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TAAR6—cervical cancer	0.00206	0.00451	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—TAAR6—cervical cancer	0.00203	0.00444	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—UBE3A—cervical cancer	0.00195	0.00428	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—TAAR6—cervical cancer	0.00193	0.00422	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—WNT5A—cervical cancer	0.00192	0.0042	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TAAR6—cervical cancer	0.00192	0.0042	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—TAAR6—cervical cancer	0.00184	0.00403	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—WNT2—cervical cancer	0.0018	0.00395	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—WNT2—cervical cancer	0.0018	0.00395	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—TAAR6—cervical cancer	0.00178	0.00391	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00178	0.0039	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00176	0.00385	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TAAR6—cervical cancer	0.00175	0.00384	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—WNT2—cervical cancer	0.00165	0.00361	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TAAR6—cervical cancer	0.00162	0.00355	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—WNT2—cervical cancer	0.00161	0.00352	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AKAP13—cervical cancer	0.00159	0.00349	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AKAP13—cervical cancer	0.00158	0.00347	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AKAP13—cervical cancer	0.00158	0.00347	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—WNT2—cervical cancer	0.0015	0.00328	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AKAP13—cervical cancer	0.00145	0.00317	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—WNT2—cervical cancer	0.00144	0.00315	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AKAP13—cervical cancer	0.00141	0.00309	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AKAP13—cervical cancer	0.00139	0.00304	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—WNT5A—cervical cancer	0.00137	0.003	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—WNT5A—cervical cancer	0.00137	0.003	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—WNT2—cervical cancer	0.00137	0.003	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TAAR6—cervical cancer	0.00136	0.00297	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TAAR6—cervical cancer	0.00134	0.00293	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AKAP13—cervical cancer	0.00132	0.0029	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AKAP13—cervical cancer	0.00131	0.00288	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—WNT2—cervical cancer	0.00126	0.00277	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKAP13—cervical cancer	0.00126	0.00276	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—WNT5A—cervical cancer	0.00125	0.00274	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TAAR6—cervical cancer	0.00125	0.00274	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKAP13—cervical cancer	0.00122	0.00268	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—WNT5A—cervical cancer	0.00122	0.00267	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKAP13—cervical cancer	0.0012	0.00263	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—WNT5A—cervical cancer	0.00113	0.00248	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKAP13—cervical cancer	0.00111	0.00243	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—WNT5A—cervical cancer	0.00109	0.00238	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TAAR6—cervical cancer	0.00109	0.00238	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—WNT2—cervical cancer	0.00106	0.00232	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—WNT2—cervical cancer	0.00104	0.00229	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00104	0.00229	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—WNT5A—cervical cancer	0.00104	0.00227	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TAAR6—cervical cancer	0.00103	0.00227	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—WNT2—cervical cancer	0.000975	0.00214	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NOTCH2—cervical cancer	0.00096	0.0021	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NOTCH2—cervical cancer	0.00096	0.0021	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—WNT5A—cervical cancer	0.000959	0.0021	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TAAR6—cervical cancer	0.000957	0.0021	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000883	0.00193	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000871	0.00191	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKAP13—cervical cancer	0.000856	0.00187	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NOTCH2—cervical cancer	0.000856	0.00187	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—WNT2—cervical cancer	0.000848	0.00186	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—WNT2—cervical cancer	0.000808	0.00177	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—WNT5A—cervical cancer	0.000802	0.00176	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NOTCH2—cervical cancer	0.000795	0.00174	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—WNT5A—cervical cancer	0.000792	0.00174	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—HES1—cervical cancer	0.000787	0.00172	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—HES1—cervical cancer	0.000787	0.00172	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TAAR6—cervical cancer	0.000766	0.00168	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TAAR6—cervical cancer	0.000756	0.00166	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—WNT2—cervical cancer	0.000747	0.00164	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKAP13—cervical cancer	0.000745	0.00163	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—WNT5A—cervical cancer	0.000739	0.00162	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKAP13—cervical cancer	0.000709	0.00155	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HES1—cervical cancer	0.000701	0.00154	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TAAR6—cervical cancer	0.000696	0.00152	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TERT—cervical cancer	0.00069	0.00151	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TERT—cervical cancer	0.00069	0.00151	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TAAR6—cervical cancer	0.000687	0.00151	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKAP13—cervical cancer	0.000656	0.00144	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HES1—cervical cancer	0.000652	0.00143	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—WNT5A—cervical cancer	0.000643	0.00141	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—FGFR3—cervical cancer	0.000633	0.00139	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—FGFR3—cervical cancer	0.000633	0.00139	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TERT—cervical cancer	0.000615	0.00135	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—WNT5A—cervical cancer	0.000612	0.00134	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NOTCH1—cervical cancer	0.000594	0.0013	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NOTCH1—cervical cancer	0.000594	0.0013	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TERT—cervical cancer	0.000571	0.00125	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—WNT5A—cervical cancer	0.000566	0.00124	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—FGFR3—cervical cancer	0.000564	0.00124	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000544	0.00119	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—WNT2—cervical cancer	0.000543	0.00119	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—WNT2—cervical cancer	0.000536	0.00117	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NOTCH1—cervical cancer	0.00053	0.00116	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—EGFR—cervical cancer	0.000529	0.00116	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—EGFR—cervical cancer	0.000529	0.00116	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKAP13—cervical cancer	0.000525	0.00115	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—FGFR3—cervical cancer	0.000524	0.00115	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000524	0.00115	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKAP13—cervical cancer	0.000518	0.00114	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOTCH2—cervical cancer	0.000518	0.00114	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NOTCH1—cervical cancer	0.000492	0.00108	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKAP13—cervical cancer	0.000477	0.00104	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—EGFR—cervical cancer	0.000472	0.00103	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKAP13—cervical cancer	0.000471	0.00103	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOTCH2—cervical cancer	0.000451	0.000989	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MTOR—cervical cancer	0.000445	0.000976	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MTOR—cervical cancer	0.000445	0.000976	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—EGFR—cervical cancer	0.000439	0.000961	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000436	0.000956	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000431	0.000943	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOTCH2—cervical cancer	0.00043	0.000941	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HES1—cervical cancer	0.000425	0.000931	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—WNT5A—cervical cancer	0.000412	0.000902	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TAAR6—cervical cancer	0.000411	0.000901	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CASP3—cervical cancer	0.00041	0.000897	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CASP3—cervical cancer	0.00041	0.000897	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—WNT5A—cervical cancer	0.000406	0.00089	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TAAR6—cervical cancer	0.000406	0.000889	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOTCH2—cervical cancer	0.000397	0.000871	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MTOR—cervical cancer	0.000397	0.000869	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CTNNB1—cervical cancer	0.000395	0.000865	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CTNNB1—cervical cancer	0.000395	0.000865	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TERT—cervical cancer	0.000372	0.000816	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HES1—cervical cancer	0.00037	0.000811	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MTOR—cervical cancer	0.000369	0.000808	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CASP3—cervical cancer	0.000365	0.0008	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HES1—cervical cancer	0.000352	0.000772	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CTNNB1—cervical cancer	0.000352	0.000771	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—STAT3—cervical cancer	0.000344	0.000754	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—STAT3—cervical cancer	0.000344	0.000754	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—FGFR3—cervical cancer	0.000342	0.000749	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CASP3—cervical cancer	0.000339	0.000743	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CTNNB1—cervical cancer	0.000327	0.000717	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HES1—cervical cancer	0.000326	0.000714	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000325	0.000713	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TERT—cervical cancer	0.000324	0.00071	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—WNT2—cervical cancer	0.000321	0.000703	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOTCH1—cervical cancer	0.000321	0.000703	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—WNT2—cervical cancer	0.000317	0.000694	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EGFR—cervical cancer	0.000313	0.000685	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EGFR—cervical cancer	0.000313	0.000685	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TERT—cervical cancer	0.000309	0.000676	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—STAT3—cervical cancer	0.000307	0.000672	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FGFR3—cervical cancer	0.000298	0.000652	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—cervical cancer	0.000288	0.000632	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EGFR—cervical cancer	0.000286	0.000626	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TERT—cervical cancer	0.000286	0.000626	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—STAT3—cervical cancer	0.000285	0.000625	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FGFR3—cervical cancer	0.000283	0.00062	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKAP13—cervical cancer	0.000282	0.000617	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOTCH1—cervical cancer	0.000279	0.000612	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EGFR—cervical cancer	0.000279	0.000611	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.000278	0.000609	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOTCH1—cervical cancer	0.000266	0.000583	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—cervical cancer	0.000263	0.000575	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—cervical cancer	0.000263	0.000575	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FGFR3—cervical cancer	0.000262	0.000574	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—cervical cancer	0.000259	0.000568	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—cervical cancer	0.000249	0.000545	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOTCH1—cervical cancer	0.000246	0.000539	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—WNT5A—cervical cancer	0.000243	0.000533	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MTOR—cervical cancer	0.00024	0.000527	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—WNT5A—cervical cancer	0.00024	0.000526	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—cervical cancer	0.000237	0.000519	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—cervical cancer	0.000234	0.000513	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CASP3—cervical cancer	0.000221	0.000485	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—cervical cancer	0.000219	0.00048	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—cervical cancer	0.000218	0.000477	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CTNNB1—cervical cancer	0.000213	0.000467	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MTOR—cervical cancer	0.000209	0.000459	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MTOR—cervical cancer	0.000199	0.000437	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CASP3—cervical cancer	0.000193	0.000422	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—STAT3—cervical cancer	0.000186	0.000407	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CTNNB1—cervical cancer	0.000186	0.000407	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MTOR—cervical cancer	0.000184	0.000404	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CASP3—cervical cancer	0.000183	0.000401	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CTNNB1—cervical cancer	0.000177	0.000387	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000171	0.000374	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CASP3—cervical cancer	0.00017	0.000371	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—cervical cancer	0.000169	0.00037	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	0.000168	0.000369	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CTNNB1—cervical cancer	0.000163	0.000358	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—STAT3—cervical cancer	0.000162	0.000354	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STAT3—cervical cancer	0.000154	0.000337	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—cervical cancer	0.000147	0.000322	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STAT3—cervical cancer	0.000142	0.000312	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—cervical cancer	0.000142	0.000311	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HES1—cervical cancer	0.00014	0.000307	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—cervical cancer	0.00014	0.000307	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HES1—cervical cancer	0.000138	0.000303	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—cervical cancer	0.000129	0.000284	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—cervical cancer	0.000123	0.00027	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TERT—cervical cancer	0.000123	0.000269	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TERT—cervical cancer	0.000121	0.000265	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—cervical cancer	0.000117	0.000257	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGFR3—cervical cancer	0.000113	0.000247	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGFR3—cervical cancer	0.000111	0.000243	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—cervical cancer	0.000109	0.000238	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	0.000106	0.000231	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	0.000104	0.000229	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—cervical cancer	9.41e-05	0.000206	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—cervical cancer	9.29e-05	0.000204	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MTOR—cervical cancer	7.92e-05	0.000173	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MTOR—cervical cancer	7.82e-05	0.000171	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CASP3—cervical cancer	7.28e-05	0.00016	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CASP3—cervical cancer	7.19e-05	0.000157	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	7.02e-05	0.000154	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	6.93e-05	0.000152	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT3—cervical cancer	6.12e-05	0.000134	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT3—cervical cancer	6.04e-05	0.000132	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—cervical cancer	5.56e-05	0.000122	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—cervical cancer	5.49e-05	0.00012	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—cervical cancer	4.67e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—cervical cancer	4.61e-05	0.000101	CbGpPWpGaD
